= CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. RESEARCH LICENSE AND COMMERCIAL OPTION AGREEMENTResearch License and Commercial Option Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020This Research License and Commercial Option Agreement (this “Agreement”) is entered into as of the 1st day of October, 2013 (“Effective Date”) by and among 22nd Century Limited, LLC (“22nd Century”) and 22nd Century Group, Inc. (“22nd Century Group”), each with its corporate headquarters at 9530 Main Street, Clarence, New York 14031, United States of America, and British American Tobacco (Investments) Limited (“BAT”), Reg. No. 00074974, with its registered office at Globe House, 1 Water Street, London WC2R 3LA, United Kingdom.
RESEARCH LICENSE AND COMMERCIAL OPTION AGREEMENTResearch License and Commercial Option Agreement • January 30th, 2014 • 22nd Century Group, Inc. • Cigarettes
Contract Type FiledJanuary 30th, 2014 Company IndustryThis Research License and Commercial Option Agreement (this “Agreement”) is entered into as of the 1st day of October, 2013 (“Effective Date”) by and among 22nd Century Limited, LLC (“22nd Century”) and 22nd Century Group, Inc. (“22nd Century Group”), each with its corporate headquarters at 9530 Main Street, Clarence, New York 14031, United States of America, and British American Tobacco (Investments) Limited (“BAT”), Reg. No. 00074974, with its registered office at Globe House, 1 Water Street, London WC2R 3LA, United Kingdom.